Medicare Enrolled
Dr. Pankaj Satija, M.D.
Brain Injury Medicine (Psychiatry & Neurology) Physician · Houston, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Satija from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Satija? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Satija
Dr. Pankaj Satija is a brain injury medicine (psychiatry & neurology) physician in Houston, TX, with 17 years in practice. Based on federal Medicare data, Dr. Satija performed 7,679 Medicare services across 1,219 unique beneficiaries.
Between the years covered by Open Payments, Dr. Satija received a total of $1,079,338 from 84 pharmaceutical and/or device companies across 2232 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in brain injury medicine (psychiatry & neurology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Satija is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice▲ Top 50% volume in TX$ $1,079,338 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,679
Medicare services
Top 50% in TX for brain injury medicine (psychiatry & neurology) physician
1,219
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~452 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, midazolam hydrochloride, per 1 mg | 2,611 | $0 | $5 |
| Dexamethasone injection (steroid) | 2,285 | $0 | $10 |
| Contrast dye for imaging (iodine-based) | 565 | $0 | $5 |
| Office visit, established patient (30-39 min) | 387 | $99 | $465 |
| Injection, methylprednisolone acetate, 40 mg | 301 | $6 | $10 |
| Office visit, established patient (20-29 min) | 215 | $66 | $394 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 211 | $40 | $633 |
| Compounded drug, not otherwise classified | 160 | $94 | $1,042 |
| Betamethasone steroid injection | 146 | $5 | $15 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | 137 | $75 | $399 |
| Ultrasonic guidance for needle placement | 136 | $47 | $228 |
| Testing for presence of drug, read by direct observation | 134 | $12 | $30 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 50 | $266 | $1,651 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 43 | $292 | $924 |
| Fluoroscopic guidance for needle placement | 36 | $91 | $312 |
| New patient office visit, complex (60-74 min) | 34 | $166 | $804 |
| Assessment of emotional or behavioral problems | 32 | $4 | $500 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 31 | $530 | $1,659 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 28 | $118 | $636 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 25 | $42 | $722 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 24 | $205 | $1,300 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 23 | $110 | $680 |
| Joint injection, major joint | 21 | $65 | $767 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 16 | $223 | $1,185 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 16 | $113 | $659 |
| Injection of substance into lower spine canal using imaging guidance | 12 | $201 | $1,102 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
80.7% medium
17.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,079,338
Total received (2018-2024)
Avg $154,191/year across 7 years
Top 33% in TX for brain injury medicine (psychiatry & neurology) physician
84
Companies
2,232
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,053,478 (97.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,526 (2.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,334 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$130,342
2023$121,702
2022$212,137
2021$186,278
2020$100,317
2019$136,291
2018$192,272
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$259,302
Amgen Inc.
$253,040
AbbVie Inc.
$177,780
Biohaven Pharmaceutical Holding Company Ltd.
$76,164
Daiichi Sankyo Inc.
$65,870
Teva Pharmaceuticals USA, Inc.
$56,042
Biohaven Pharmaceuticals, Inc.
$52,453
Lilly USA, LLC
$51,300
Allergan, Inc.
$25,734
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18,929
Supernus Pharmaceuticals, Inc.
$8,787
AstraZeneca Pharmaceuticals LP
$5,575
PFIZER INC.
$5,224
Abbott Laboratories
$3,527
Medtronic, Inc.
$3,231
Medtronic USA, Inc.
$2,662
Lundbeck LLC
$2,146
Novartis Pharmaceuticals Corporation
$1,296
UCB, Inc.
$814
Vertiflex, Inc.
$805
Nevro Corp.
$525
Merz North America, Inc.
$482
Medtronic Vascular, Inc.
$461
Merz Pharmaceuticals, LLC
$423
Takeda Pharmaceuticals U.S.A., Inc.
$357
Genesys Orthopedics Systems, L.L.C.
$352
Nuvectra Corporation
$339
Inspire Medical Systems, Inc.
$328
Biogen, Inc.
$311
Collegium Pharmaceutical, Inc.
$299
Allergan Inc.
$265
MERZ NORTH AMERICA, INC.
$231
SK Life Science, Inc.
$225
BOSTON SCIENTIFIC CORPORATION
$221
Grifols USA, LLC
$216
Upsher-Smith Laboratories LLC
$207
AQUESTIVE THERAPEUTICS, INC.
$197
IDORSIA PHARMACEUTICALS US INC
$194
GRT US Holding, Inc.
$178
ARBOR PHARMACEUTICALS, INC.
$166
TerSera Therapeutics LLC
$161
JAZZ PHARMACEUTICALS INC.
$160
Eisai Inc.
$157
SI-BONE, Inc.
$154
Boston Scientific Corporation
$116
Jazz Pharmaceuticals Inc.
$114
LivaNova USA, Inc.
$111
Promius Pharma LLC
$109
Azurity Pharmaceuticals, Inc.
$98
Scilex Pharmaceuticals Inc.
$93
CATALYST PHARMACEUTICALS, INC.
$91
EISAI INC.
$81
UPSHER-SMITH LABORATORIES LLC
$76
SCILEX PHARMACEUTICALS INC.
$71
Saluda Medical Americas, Inc.
$71
Sunovion Pharmaceuticals Inc.
$71
FUJIFILM SonoSite, Inc.
$66
Bausch Health US, LLC
$63
Horizon Therapeutics plc
$60
Stimwave Technologies Incorporated
$60
US WorldMeds, LLC
$53
Arbor Pharmaceuticals, Inc.
$51
Vertos Medical, Inc.
$50
Pernix Therapeutics Holdings, Inc.
$45
BIOTRONIK NRO, Inc.
$44
Avanir Pharmaceuticals, Inc.
$38
Vertical Pharmaceuticals, LLC
$38
Shionogi Inc
$37
DePuy Synthes Sales Inc.
$28
Purdue Pharma L.P.
$27
Egalet US Inc
$26
RedHill Biopharma Inc.
$26
BioDelivery Sciences International, Inc.
$25
Assertio Therapeutics, Inc.
$25
Horizon Pharma plc
$24
Amneal Pharmaceuticals LLC
$24
Innovation Technologies Inc
$22
Aziyo Biologics, Inc.
$22
Zyla Life Sciences
$21
Zyla Life Sciences, Inc.
$20
Almatica Pharma LLC
$16
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$14
IBSA Pharma Inc.
$12
Sentynl Therapeutics, Inc.
$11
Top 3 companies account for 63.9% of total payments
Associated products mentioned in payments ›
ADAPTIVESTIM · ADUHELM · AIMOVIG · AJOVY · AMYVID · APTIOM · ARYMO ER · AUTOFILL · AVONEX · Aimovig · Algovita · Amitiza · Axium Sheath Braided DRG · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Briviact · CAMBIA · Cambia · ClosureFast · DUEXIS · Dayvigo · ECM Patch · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Edarbi · Edarbyclor · Evoke SCS · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GRALISE · Gamunex-C · General - Pain Management · HORIZANT · HYQVIA · Horizant · INSPIRE · INTELLIS · INTELLIS ADAPTIVESTIM · IRRISEPT · KESIMPTA · KISUNLA · KYPHON Balloon Kyphoplasty · LORZONE · LUCEMYRA · LYRICA · Levorphanol · Licart · Lucemyra · Lucemyra/Lofexidine · MIGRANAL · MONOVISC · MOVANTIK · Morphabond ER · Movantik · NUEDEXTA · NURTEC ODT · Nayzilam · Nucynta · Nuedexta · ORTHOVISC · OXTELLAR XR · Omnia · PENNSAID · PRIALT · PROCLAIM · Pouch · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Prospera · Protege Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · Qutenza · RELEXXII · RELISTOR · RELISTOR ORAL · RESTORE · REYVOW · RoxyBond · S Series Ultrasound System · SACROILIAC JOINT FUSION SYSTEM · SPECTRA WAVEWRITER · SPINRAZA · SPRIX · SYMPAZAN · SYMPROIC · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · Superion ISS · Superion Indirect Decompression System · Symproic · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · UBRELVY · V-LOC 180 · VIGADRONE (vigabatrin) for Oral Solution · VNS - Symmetry · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VYEPTI · WAVEWRITER ALPHA · XCOPRI · XEOMIN · XTAMPZA · Xeomin · Xtampza ER · ZEMBRACE SYMTOUCH · ZOHYDRO ER · ZOMIG · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zembrace SymTouch Sumatriptan Injection · mild Device Kit · movantik
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in brain injury medicine (psychiatry & neurology) physician and does not inherently indicate bias, but patients may wish to be aware.
Equivalent to $14,056 per 100 Medicare services performed
Geographic Context
Brain Injury Medicine (Psychiatry & Neurology) Physicians within 10 mi
2
Per 100K population
0.0
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Satija is a mixed practice specialist, with moderate Medicare volume, and speaking/promotional industry engagement, with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Satija experienced with injection, midazolam hydrochloride, per 1 mg?
Based on Medicare claims data, Dr. Satija performed 2,611 injection, midazolam hydrochloride, per 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Satija receive payments from pharmaceutical companies?
Yes. Dr. Satija received a total of $1,079,338 from 84 companies across 2,232 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Satija's costs compare to other brain injury medicine (psychiatry & neurology) physicians in Houston?
Dr. Satija's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Satija) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Brain Injury Medicine (Psychiatry & Neurology) Physicians in Houston
Browse brain injury medicine (psychiatry & neurology) physicians in Houston ranked by procedure volume and transparency data.
Highest volume
Top Brain Injury Medicine (Psychiatry & Neurology) Physicians in TX
Brain Injury Medicine (Psychiatry & Neurology) Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Brain Injury Medicine (Psychiatry & Neurology) Physicians in TX
Which TX brain injury medicine (psychiatry & neurology) physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology